IBDEI2WL ; ; 04-FEB-2020
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,46311,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,46311,1,3,0)
;;=3^Low-Tension Glaucoma,Mild,Bilateral
;;^UTILITY(U,$J,358.3,46311,1,4,0)
;;=4^H40.1231
;;^UTILITY(U,$J,358.3,46311,2)
;;=^5005768
;;^UTILITY(U,$J,358.3,46312,0)
;;=H40.1233^^176^2305^20
;;^UTILITY(U,$J,358.3,46312,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,46312,1,3,0)
;;=3^Low-Tension Glaucoma,Severe,Bilateral
;;^UTILITY(U,$J,358.3,46312,1,4,0)
;;=4^H40.1233
;;^UTILITY(U,$J,358.3,46312,2)
;;=^5005770
;;^UTILITY(U,$J,358.3,46313,0)
;;=H40.011^^176^2305^21
;;^UTILITY(U,$J,358.3,46313,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,46313,1,3,0)
;;=3^Open Angle w/ Borderline Findings,Low Risk,Right Eye
;;^UTILITY(U,$J,358.3,46313,1,4,0)
;;=4^H40.011
;;^UTILITY(U,$J,358.3,46313,2)
;;=^5005724
;;^UTILITY(U,$J,358.3,46314,0)
;;=H40.012^^176^2305^22
;;^UTILITY(U,$J,358.3,46314,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,46314,1,3,0)
;;=3^Open Angle w/ Borderline Findings,Low Risk,Left Eye
;;^UTILITY(U,$J,358.3,46314,1,4,0)
;;=4^H40.012
;;^UTILITY(U,$J,358.3,46314,2)
;;=^5005725
;;^UTILITY(U,$J,358.3,46315,0)
;;=H59.41^^176^2305^25
;;^UTILITY(U,$J,358.3,46315,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,46315,1,3,0)
;;=3^Blebitis,Stage 1
;;^UTILITY(U,$J,358.3,46315,1,4,0)
;;=4^H59.41
;;^UTILITY(U,$J,358.3,46315,2)
;;=^5006426
;;^UTILITY(U,$J,358.3,46316,0)
;;=H40.1111^^176^2305^6
;;^UTILITY(U,$J,358.3,46316,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,46316,1,3,0)
;;=3^Primary Open-Angle Glaucoma,Mild Stage,Right Eye
;;^UTILITY(U,$J,358.3,46316,1,4,0)
;;=4^H40.1111
;;^UTILITY(U,$J,358.3,46316,2)
;;=^5138537
;;^UTILITY(U,$J,358.3,46317,0)
;;=H40.1121^^176^2305^7
;;^UTILITY(U,$J,358.3,46317,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,46317,1,3,0)
;;=3^Primary Open-Angle Glaucoma,Mild Stage,Left Eye
;;^UTILITY(U,$J,358.3,46317,1,4,0)
;;=4^H40.1121
;;^UTILITY(U,$J,358.3,46317,2)
;;=^5138542
;;^UTILITY(U,$J,358.3,46318,0)
;;=H40.013^^176^2305^4
;;^UTILITY(U,$J,358.3,46318,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,46318,1,3,0)
;;=3^Glaucoma Suspect,Low Risk,Bilateral
;;^UTILITY(U,$J,358.3,46318,1,4,0)
;;=4^H40.013
;;^UTILITY(U,$J,358.3,46318,2)
;;=^5005726
;;^UTILITY(U,$J,358.3,46319,0)
;;=H40.023^^176^2305^5
;;^UTILITY(U,$J,358.3,46319,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,46319,1,3,0)
;;=3^Glaucoma Suspect,High Risk,Bilateral
;;^UTILITY(U,$J,358.3,46319,1,4,0)
;;=4^H40.023
;;^UTILITY(U,$J,358.3,46319,2)
;;=^5005730
;;^UTILITY(U,$J,358.3,46320,0)
;;=H40.1132^^176^2305^11
;;^UTILITY(U,$J,358.3,46320,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,46320,1,3,0)
;;=3^Primary Open-Angle Gluacoma,Mod Stage,Bilateral
;;^UTILITY(U,$J,358.3,46320,1,4,0)
;;=4^H40.1132
;;^UTILITY(U,$J,358.3,46320,2)
;;=^5138548
;;^UTILITY(U,$J,358.3,46321,0)
;;=H40.1232^^176^2305^19
;;^UTILITY(U,$J,358.3,46321,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,46321,1,3,0)
;;=3^Low-Tension Glaucoma,Mod,Bilateral
;;^UTILITY(U,$J,358.3,46321,1,4,0)
;;=4^H40.1232
;;^UTILITY(U,$J,358.3,46321,2)
;;=^5005769
;;^UTILITY(U,$J,358.3,46322,0)
;;=H40.1113^^176^2305^12
;;^UTILITY(U,$J,358.3,46322,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,46322,1,3,0)
;;=3^Primary Open-Angle Glaucoma,Sev Stage,Right Eye
;;^UTILITY(U,$J,358.3,46322,1,4,0)
;;=4^H40.1113
;;^UTILITY(U,$J,358.3,46322,2)
;;=^5138539
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI2WL 3773 printed Sep 23, 2025@20:13:15 Page 2
IBDEI2WL ; ; 04-FEB-2020
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,46311,1,0)
+2 ;;=^358.31IA^4^2
+3 ;;^UTILITY(U,$J,358.3,46311,1,3,0)
+4 ;;=3^Low-Tension Glaucoma,Mild,Bilateral
+5 ;;^UTILITY(U,$J,358.3,46311,1,4,0)
+6 ;;=4^H40.1231
+7 ;;^UTILITY(U,$J,358.3,46311,2)
+8 ;;=^5005768
+9 ;;^UTILITY(U,$J,358.3,46312,0)
+10 ;;=H40.1233^^176^2305^20
+11 ;;^UTILITY(U,$J,358.3,46312,1,0)
+12 ;;=^358.31IA^4^2
+13 ;;^UTILITY(U,$J,358.3,46312,1,3,0)
+14 ;;=3^Low-Tension Glaucoma,Severe,Bilateral
+15 ;;^UTILITY(U,$J,358.3,46312,1,4,0)
+16 ;;=4^H40.1233
+17 ;;^UTILITY(U,$J,358.3,46312,2)
+18 ;;=^5005770
+19 ;;^UTILITY(U,$J,358.3,46313,0)
+20 ;;=H40.011^^176^2305^21
+21 ;;^UTILITY(U,$J,358.3,46313,1,0)
+22 ;;=^358.31IA^4^2
+23 ;;^UTILITY(U,$J,358.3,46313,1,3,0)
+24 ;;=3^Open Angle w/ Borderline Findings,Low Risk,Right Eye
+25 ;;^UTILITY(U,$J,358.3,46313,1,4,0)
+26 ;;=4^H40.011
+27 ;;^UTILITY(U,$J,358.3,46313,2)
+28 ;;=^5005724
+29 ;;^UTILITY(U,$J,358.3,46314,0)
+30 ;;=H40.012^^176^2305^22
+31 ;;^UTILITY(U,$J,358.3,46314,1,0)
+32 ;;=^358.31IA^4^2
+33 ;;^UTILITY(U,$J,358.3,46314,1,3,0)
+34 ;;=3^Open Angle w/ Borderline Findings,Low Risk,Left Eye
+35 ;;^UTILITY(U,$J,358.3,46314,1,4,0)
+36 ;;=4^H40.012
+37 ;;^UTILITY(U,$J,358.3,46314,2)
+38 ;;=^5005725
+39 ;;^UTILITY(U,$J,358.3,46315,0)
+40 ;;=H59.41^^176^2305^25
+41 ;;^UTILITY(U,$J,358.3,46315,1,0)
+42 ;;=^358.31IA^4^2
+43 ;;^UTILITY(U,$J,358.3,46315,1,3,0)
+44 ;;=3^Blebitis,Stage 1
+45 ;;^UTILITY(U,$J,358.3,46315,1,4,0)
+46 ;;=4^H59.41
+47 ;;^UTILITY(U,$J,358.3,46315,2)
+48 ;;=^5006426
+49 ;;^UTILITY(U,$J,358.3,46316,0)
+50 ;;=H40.1111^^176^2305^6
+51 ;;^UTILITY(U,$J,358.3,46316,1,0)
+52 ;;=^358.31IA^4^2
+53 ;;^UTILITY(U,$J,358.3,46316,1,3,0)
+54 ;;=3^Primary Open-Angle Glaucoma,Mild Stage,Right Eye
+55 ;;^UTILITY(U,$J,358.3,46316,1,4,0)
+56 ;;=4^H40.1111
+57 ;;^UTILITY(U,$J,358.3,46316,2)
+58 ;;=^5138537
+59 ;;^UTILITY(U,$J,358.3,46317,0)
+60 ;;=H40.1121^^176^2305^7
+61 ;;^UTILITY(U,$J,358.3,46317,1,0)
+62 ;;=^358.31IA^4^2
+63 ;;^UTILITY(U,$J,358.3,46317,1,3,0)
+64 ;;=3^Primary Open-Angle Glaucoma,Mild Stage,Left Eye
+65 ;;^UTILITY(U,$J,358.3,46317,1,4,0)
+66 ;;=4^H40.1121
+67 ;;^UTILITY(U,$J,358.3,46317,2)
+68 ;;=^5138542
+69 ;;^UTILITY(U,$J,358.3,46318,0)
+70 ;;=H40.013^^176^2305^4
+71 ;;^UTILITY(U,$J,358.3,46318,1,0)
+72 ;;=^358.31IA^4^2
+73 ;;^UTILITY(U,$J,358.3,46318,1,3,0)
+74 ;;=3^Glaucoma Suspect,Low Risk,Bilateral
+75 ;;^UTILITY(U,$J,358.3,46318,1,4,0)
+76 ;;=4^H40.013
+77 ;;^UTILITY(U,$J,358.3,46318,2)
+78 ;;=^5005726
+79 ;;^UTILITY(U,$J,358.3,46319,0)
+80 ;;=H40.023^^176^2305^5
+81 ;;^UTILITY(U,$J,358.3,46319,1,0)
+82 ;;=^358.31IA^4^2
+83 ;;^UTILITY(U,$J,358.3,46319,1,3,0)
+84 ;;=3^Glaucoma Suspect,High Risk,Bilateral
+85 ;;^UTILITY(U,$J,358.3,46319,1,4,0)
+86 ;;=4^H40.023
+87 ;;^UTILITY(U,$J,358.3,46319,2)
+88 ;;=^5005730
+89 ;;^UTILITY(U,$J,358.3,46320,0)
+90 ;;=H40.1132^^176^2305^11
+91 ;;^UTILITY(U,$J,358.3,46320,1,0)
+92 ;;=^358.31IA^4^2
+93 ;;^UTILITY(U,$J,358.3,46320,1,3,0)
+94 ;;=3^Primary Open-Angle Gluacoma,Mod Stage,Bilateral
+95 ;;^UTILITY(U,$J,358.3,46320,1,4,0)
+96 ;;=4^H40.1132
+97 ;;^UTILITY(U,$J,358.3,46320,2)
+98 ;;=^5138548
+99 ;;^UTILITY(U,$J,358.3,46321,0)
+100 ;;=H40.1232^^176^2305^19
+101 ;;^UTILITY(U,$J,358.3,46321,1,0)
+102 ;;=^358.31IA^4^2
+103 ;;^UTILITY(U,$J,358.3,46321,1,3,0)
+104 ;;=3^Low-Tension Glaucoma,Mod,Bilateral
+105 ;;^UTILITY(U,$J,358.3,46321,1,4,0)
+106 ;;=4^H40.1232
+107 ;;^UTILITY(U,$J,358.3,46321,2)
+108 ;;=^5005769
+109 ;;^UTILITY(U,$J,358.3,46322,0)
+110 ;;=H40.1113^^176^2305^12
+111 ;;^UTILITY(U,$J,358.3,46322,1,0)
+112 ;;=^358.31IA^4^2
+113 ;;^UTILITY(U,$J,358.3,46322,1,3,0)
+114 ;;=3^Primary Open-Angle Glaucoma,Sev Stage,Right Eye
+115 ;;^UTILITY(U,$J,358.3,46322,1,4,0)
+116 ;;=4^H40.1113
+117 ;;^UTILITY(U,$J,358.3,46322,2)
+118 ;;=^5138539
